Saving Lives • Restoring Health • Giving Hope
Saving Lives, Restoring Health and Giving Hope isn’t just our mission; it has been our sole motivation since 1982. That commitment has driven us to become a world leader in allograft bio-implants, with an unmatched safety record that makes us the most-trusted partner in the field. It also has focused our efforts to aggressively innovate bio-implant technologies and cellular therapies and to lead in regenerative medicine.
Vascular
Allograft Bio-Implants for Vascular Procedures
AngioGRAFT® cryopreserved vascular allografts are the safe choice for managing vascular reconstruction. In peripheral bypass surgery, LifeNet Health femoral and saphenous vessel allografts provide an effective clinical option. When bypassing stenosed vascular segments in the treatment of peripheral vascular disease, or in CABG procedures, acceptable native vessels are often not available. LifeNet Health cryopreserved vessels are a natural solution for peripheral bypass procedures and reconstruction. When confronting failing A/V access grafts, consider LifeNet Health allografts as an ideal natural solution for dialysis access and the replacement of infected synthetic dialysis grafts.
Femoral Vessels
Description
AngioGRAFT® Femoral Artery and Vein
Benefits
• Human tissue-most closely resembles native tissue
• Resistance to infection
• Vein allografts are an alternative conduit for patients lacking available autogenous veins
Clinical Application
• Patients in whom an autologous fistula is not possible
• Replacing infected AV access grafts or in patients who are at risk of AV access infections
• Patients with a limited number of AV access sites
• Peripheral vascular disease
Saphenous Vein
Description
AngioGRAFT® Cryopreserved Saphenous Vein
Benefits
• Human tissue-most closely resembles native tissue
• Resistance to infection
• Vein allografts are an alternative conduit for patients lacking available autogenous veins
Clinical Application
• Peripheral vascular disease
• CABG
• Patients with infected fields or at risk of infection
• AV access
Aortoiliac Artery
Description
A safe and efficacious alternative to synthetic grafts, in abdominal aortoiliac procedures.
Benefits
• Allograft tissue most closely resembles the patient’s native tissue
• Convenient: Available in 3 configurations, and measured in both flaccid and pressurized diameter sizing
• Safety: Allografts offer a high resistance to infection1, 2
Clinical Application
• Infected Synthetic Graft Replacement
• Trauma
• Mycotic Aneurysm
• Aortoenteric Fistula
Cardiac
Allograft Bio-Implants for Cardiac Procedures
Suitable for a wide variety of complex congenital heart defects, as well as for adults with extensive valvular disease. The CardioGRAFT® line of tissue grafts offers heart valves, repair grafts, conduits and decellularized tissue grafts with Matracell® decellularization technology.
Aortic Heart Valve
Description
CardioGRAFT® Aortic Heart Valve
Benefits
• No anticoagulation therapy required
• Exceptionally good hemodynamic performance
• No immunosuppressive therapy needed
• Non-thrombogenic
• Non-hemolytic
• Human tissue - most closely resembles native tissue
• High resistance to infection
Clinical Application
• Left side/aortic reconstruction
• Aortic stenosis/atresia
• Hypoplastic left heart
• Repair of RVOTs (Right Ventricular Outflow Tract)
Pulmonary Heart Valve
Description
CardioGRAFT® Pulmonary Heart Valve
Benefits
• No Anticoagulation therapy required
• Non-thrombogenic
• Non-hemolytic
• No immunosuppressive therapy required
• Human tissue - most closely resembles native tissue
• High resistance to infection
Clinical Application
• Right side/pulmonary reconstructions
• Hypoplastic left heart (modified Fontan)
• Ross procedure
• Truncus arteriosus
• Pulmonary atresia
• Single ventricle/double outlet (Fontan)
• Pulmonary root stenosis
Ascending Aorta (non-valved) Conduit
Description
CardioGRAFT® Ascending Aorta non-valved
Benefits
• Non-thrombogenic
• Non-hemolytic
• No immunosuppressive therapy required
• Human tissue - most closely resembles native tissue
• High resistance to infection
• No anticoagulation therapy required
Clinical Application
• Conduit repair
Pulmonary Artery (non-valved) Conduit
Description
CardioGRAFT® Pulmonary Artery (non valved)
Benefits
• No Anticoagulation therapy required
• Non-thrombogenic
• Non-hemolytic
• No immunosuppressive therapy required
• Human tissue - most closely resembles native tissue
• High resistance to infection
Clinical Application
• Right side/pulmonary reconstructions
• Tetralogy of Fallot
• Pulmonary atresia
• Single ventricle/double outlet (Fontan)
• Truncus arteriosus
• Pulmonary root stenosis
Thoracic Aorta Conduit
Description
CardioGRAFT® Thoracic Aorta
Benefits
• No Anticoagulation therapy required
• Non-thrombogenic
• Non-hemolytic
• No immunosuppressive therapy required
• Human tissue - most closely resembles native tissue
• High resistance to infection
Clinical Application
• Infected descending aorta
• Conduit repair
• Extra-cardiac shunt
Hemi-Pulmonary Artery Repair Graft
Description
CardioGRAFT® Hemi-Pulmonary Artery
Benefits
• No Anticoagulation therapy required
• Non-thrombogenic
• Non-hemolytic
• No immunosuppressive therapy required
• Human tissue - most closely resembles native tissue
• High resistance to infection
Clinical Application
• Tetralogy of Fallot
• Pulmonary atresia
• Single ventricle/double outlet (Fontan)
• Truncus arteriosus
• Transposition of great vessels
• Hypoplastic left heart (modified Fontan)
• Aortic stenosis/atresia
Mono Cusp Patch Repair Graft
Description
CardioGRAFT® Mono Cusp Patch
Benefits
• Single valved section of main pulmonary trunk
• Original annulus diameter
• Length and width measured in centimeters
• No minimum or maximum width
Clinical Application
• Tetralogy of Fallot
• RVOT/root enlargement procedures
Pulmonary Patch Repair Graft
Description
CardioGRAFT® Pulmonary Patch section produced from the main pulmonary artery
Benefits
• No anticoagulation therapy required
• Non-thromogenic
• Non-hemolytic
• No immunosuppressive therapy required
• Human tissue - most closely resembles native tissue
• High resistance to infection
Clinical Application
• Right side/pulmonary reconstructions
• Tetralogy of Fallot
• Single ventricle/double outlet (Fontan)
• Truncus arterious; ASD/VSD repair
Decellularized Pulmonary Patch Repair Graft
Description
CardioGRAFT® Decellularized Pulmonary Patch with Matracell®
Clinical Application
• RVOT Repair
Decellularized Hemi-Pulmonary Artery Repair Graft
Description
CardioGRAFT® Decellularized Hemi-Pulmonary Artery with Matracell®
Benefits
• Matracell safely removes donor cells and DNA without sacrificing the biomechanical strength of the allograft bio-implant
Clinical Application
• RVOT Repair